These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7118530)

  • 41. [Radiological investigation of prolactin-producing pituitary microadenomas (author's transl)].
    Smaltino F; Bernini FP; Elefante R; La Tessa G
    Radiol Med; 1981 Jun; 67(6):467-72. PubMed ID: 7196597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinical presentation and biochemical diagnosis of acromegaly and gigantism.
    Jialal I; Nathoo BC; Joubert S; Asmal AC; Pillay NL
    S Afr Med J; 1982 Apr; 61(17):617-20. PubMed ID: 6805079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of acromegaly by the surgical approach through the sphenoid bone. I. Clinical results].
    Wisławski J; Hartwig W; Kasperlik-Załuska A; Ostrowski K
    Neurol Neurochir Pol; 1982; 16(4):281-6. PubMed ID: 6292760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extraocular muscle enlargement in acromegaly.
    Dal Pozzo G; Boschi MC
    J Comput Assist Tomogr; 1982 Aug; 6(4):706-7. PubMed ID: 7119187
    [No Abstract]   [Full Text] [Related]  

  • 46. Skull changes in pituitary dwarfism and the syndrome of familial dwarfism with high plasma immunoreactive growth hormone--a Roentgenologic study.
    Scharf A; Laron Z
    Horm Metab Res; 1972 Mar; 4(2):93-7. PubMed ID: 5028227
    [No Abstract]   [Full Text] [Related]  

  • 47. A critical evaluation of interval sella turcica measurements after irradiation for acromegaly.
    Jacobs JB; Kagan AR
    J Clin Endocrinol Metab; 1972 Aug; 35(2):315-6. PubMed ID: 5072360
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of growth hormone on sleep energy].
    Aström CP; Trojaborg W
    Ugeskr Laeger; 1994 Oct; 156(40):5849-52. PubMed ID: 7985277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spontaneous remission of acromegaly or gigantism due to subclinical apoplexy of pituitary growth hormone adenoma.
    Wang XL; Dou JT; Lü ZH; Zhong WW; Ba JM; Jin D; Lu JM; Pan CY; Mu YM
    Chin Med J (Engl); 2011 Nov; 124(22):3820-3. PubMed ID: 22340248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Serum growth hormone levels in patients with brain tumors].
    Vinogradova IN; Pronina TS
    Vopr Neirokhir; 1967; 31(1):12-4. PubMed ID: 4297988
    [No Abstract]   [Full Text] [Related]  

  • 51. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors.
    Ho PJ; Jaffe CA; Friberg RD; Chandler WF; Barkan AL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1403-10. PubMed ID: 7911124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cephalometric changes in acromegaly].
    Morăraşu C; Burlui V; Zbranca E
    Rev Med Chir Soc Med Nat Iasi; 1997; 101(1-2):120-4. PubMed ID: 10756739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutis verticis gyrata: its computed tomographic demonstration in acromegaly.
    Kolawole TM; Al Orainy IA; Patel PJ; Fathuddin S
    Eur J Radiol; 1998 May; 27(2):145-8. PubMed ID: 9639140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acromegaly with an adenomatous pharyngeal pituitary.
    Corenblum B; LeBlanc FE; Watanabe M
    JAMA; 1980 Apr; 243(14):1456-7. PubMed ID: 7359718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Phlebography of the cavernous and intercavernous sinuses; an investigation complementary to CT detecting intrasellar space-occupying lesions].
    Smaltino F; Iaccarino V; de Divitiis E; Cirillo S; Elefante R; Spaziante R
    Radiol Med; 1982; 68(7-8):565-9. PubMed ID: 7134507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
    Bevan JS; Atkin SL; Atkinson AB; Bouloux PM; Hanna F; Harris PE; James RA; McConnell M; Roberts GA; Scanlon MF; Stewart PM; Teasdale E; Turner HE; Wass JA; Wardlaw JM
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4554-63. PubMed ID: 12364434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acromegaly, diabetes insipidus, and visual loss caused by metastatic growth hormone-releasing hormone-producing malignant pancreatic endocrine tumor in the pituitary gland. Case report.
    Genka S; Soeda H; Takahashi M; Katakami H; Sanno N; Osamura Y; Fuchinoue T; Teramoto A
    J Neurosurg; 1995 Oct; 83(4):719-23. PubMed ID: 7674023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acromegaly. Clinical and biochemical features in 500 patients.
    Ezzat S; Forster MJ; Berchtold P; Redelmeier DA; Boerlin V; Harris AG
    Medicine (Baltimore); 1994 Sep; 73(5):233-40. PubMed ID: 7934807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis of primary empty sella syndrome by computed tomography.
    Ketonen L; Kuuliala I
    Ann Clin Res; 1979 Aug; 11(4):125-8. PubMed ID: 517991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variable skeletal anatomical features of acromegaly in the skull and craniocervical junction.
    Piagkou M; Manolakos O; Troupis T; Lazaridis N; Laios K; Samolis A; Natsis K
    Acta Med Acad; 2017 Nov; 46(2):162-168. PubMed ID: 29338280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.